346 related articles for article (PubMed ID: 16312835)
21. [Preliminary results concerning the value of chemotherapy in the treatment of inoperable bronchial carcinoma (excluding small-cell anaplastic carcinoma)].
Quoix E; Pelletier A; Schaller M; Pillement P; Dietemann-Molard A; Klein T; Spielmann P; Orion B; Chaix C
Rev Pneumol Clin; 1984; 40(2):127-9. PubMed ID: 6374840
[TBL] [Abstract][Full Text] [Related]
22. [Role of radiotherapy in the framework of curative chemotherapy concept in local advanced non-small-cell bronchial carcinoma].
Plasswilm L
Strahlenther Onkol; 1995 May; 171(5):306-8. PubMed ID: 7770790
[No Abstract] [Full Text] [Related]
23. Cisplatin-induced autonomic neuropathy.
Rosenfeld CS; Broder LE
Cancer Treat Rep; 1984 Apr; 68(4):659-60. PubMed ID: 6538810
[TBL] [Abstract][Full Text] [Related]
24. [Effect of the pulmonary artery infusion chemotherapy of non-small cel lung cancer].
Fukuhara H; Oomura M; Sasaki H
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2469-72. PubMed ID: 2546507
[No Abstract] [Full Text] [Related]
25. Failure of the perioperative PCV neoadjuvant polychemotherapy in resectable bronchogenic non-small cell carcinoma. Results from a randomized phase II trial.
Dautzenberg B; Benichou J; Allard P; Lebeau B; Coetmeur D; Brechot JM; Postal MJ; Chastang C
Cancer; 1990 Jun; 65(11):2435-41. PubMed ID: 2159838
[TBL] [Abstract][Full Text] [Related]
26. [On ''Multimodal treatment of clinical non-small cell N2 bronchogenic carcinoma: what is the answer?''].
González Aragoneses F
Arch Bronconeumol; 2007 Mar; 43(3):183-4; author reply 184. PubMed ID: 17386198
[No Abstract] [Full Text] [Related]
27. Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial.
Loehrer PJ; Birch R; Kramer BS; Greco FA; Einhorn LH
Cancer Treat Rep; 1986 Jul; 70(7):919-20. PubMed ID: 3013402
[No Abstract] [Full Text] [Related]
28. Combination chemotherapy for non-small cell bronchogenic carcinoma with bleomycin, doxorubicin, methotrexate, and cis-dichlorodiammineplatinum(II) (BAMP).
Vogl SE; Wollner D; Kaplan BH; Berenzweig M
Cancer Treat Rep; 1980; 64(4-5):717-9. PubMed ID: 6159081
[No Abstract] [Full Text] [Related]
29. [Clinical advances in the chemotherapy of non-small cell lung cancer].
Liao ML; Cheng BJ
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):480-2. PubMed ID: 15312563
[No Abstract] [Full Text] [Related]
30. Elderly patients with advanced non-small-cell lung cancer.
Belani CP
Clin Lung Cancer; 2003 Sep; 5(2):76. PubMed ID: 14596687
[No Abstract] [Full Text] [Related]
31. [Management of non-small-cell bronchial cancers. Which chemotherapy for a stage IV?].
Quoix E
Rev Mal Respir; 1999 Jan; 16 Suppl 3():S122-5. PubMed ID: 10088281
[No Abstract] [Full Text] [Related]
32. [Clinical study of two chemotherapeutic combinations in the treatment of small-cell bronchogenic carcinoma].
Dangubić V; Vukov N; Mrda V; Spasić D; Sikimić S; Popvić D; Perunović O; Bjelić R
Zb Vojnomed Akad; 1983; 25():40-4. PubMed ID: 6099941
[No Abstract] [Full Text] [Related]
33. [Preoperative chemotherapy for non-small-cell lung cancer].
Depierre A
Rev Pneumol Clin; 2000 Jun; 56(3):173-4. PubMed ID: 10880943
[No Abstract] [Full Text] [Related]
34. [A must: evaluation of adjuvant chemotherapy in bronchogenic cancers by a randomized trial].
Depierre A; Chastang C; Lebeau B; Clavier J; Milleron B; Brambilla C; Quoix E; Lemarié E
Rev Pneumol Clin; 1992; 48(2):45-7. PubMed ID: 1329178
[No Abstract] [Full Text] [Related]
35. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: EST 2575, generation III, HAM versus CAMP.
Ruckdeschel JC; Mehta CR; Salazar OM; Creech RH; Sponzo RW
Cancer Treat Rep; 1981; 65(11-12):959-63. PubMed ID: 6794909
[TBL] [Abstract][Full Text] [Related]
37. [A chemotherapy regimen including CDDP in patients with bronchogenic carcinoma--a comparison between bronchial artery infusion and intravenous administration].
Komatsu H; Kawamura M; Satou K; Yoneda R
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3175-9. PubMed ID: 3465274
[TBL] [Abstract][Full Text] [Related]
38. [Small cell carcinoma of the lung. Combined therapy with cytostatics].
Seim H; Gulsvik A; Tausjø J; Lexow P
Tidsskr Nor Laegeforen; 1985 Oct; 105(28):1956-8. PubMed ID: 3000018
[No Abstract] [Full Text] [Related]
39. [Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].
González Larriba JL; Ordóñez Gallego A; Díaz Pérez MA; García de Paredes ML; Zamora P; Montero García JM
Med Clin (Barc); 1984 May; 82(19):836-9. PubMed ID: 6330470
[No Abstract] [Full Text] [Related]
40. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].
Sanz Ortiz J; Saiz García F
Med Clin (Barc); 1982 Nov 16-30; 79(9):403-6. PubMed ID: 6296560
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
